The back-and-forth over the Department of Health and Human Services rule requiring inclusion of list prices in TV drug ads had advertisers scrambling to file Form 2253 submissions to the FDA.
Over the past five years, MM&M has honored 200 individuals as Healthcare Transformers. Here’s how they break down across specialty, geography and gender. Tap the ‘+’ to expand the map.
A closer look at the impact of the FDA’s record-breaking orphan drug approvals in 2018.
Results from MM&M and Sermo’s survey show physicians’ preferences and attitude toward TV consumption and the ads that come with it.
A recent IQVIA report breaks down global medicine spending and eyes what lies ahead.
The healthcare world has awakened to the importance of customer data.
This year’s Top of Mind for Top Health Systems report touches on everything from the threat posed by big tech, to interoperability, to the finances underpinning telehealth.
Spots that claim a drug has caused serious side effects or death can affect how patients take their medicine and how doctors prescribe it, according to research from the Partnership to Protect Patient Health.
Not surprisingly, transparency and personalization top the list of patient priorities.
Data from Rock Health suggests digital health tools aren’t as popular as some might believe.
Please login or register first to view this content.
